13F filing recap · Q4 2020
What did Lone Pine Capital buy in Q4 2020?
Reported stock-position changes between this filing and the previous one.
Stock value
$27.51B
Positions
41
Estimated turnover
48.6%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
New positions
SNAPSnap Inc.$976.89Mreported value+19.51M sharesCVNACarvana Co.$586.46Mreported value+2.45M sharesBILIBilibili Inc.$514.67Mreported value+6.00M sharesFTCHFarfetch Limited$514.60Mreported value+8.06M sharesFISFidelity National Information Services, Inc.$396.07Mreported value+2.80M sharesDASHDoordash, Inc.$322.18Mreported value+2.26M sharesMDBMongodb, Inc.$315.89Mreported value+879.8K shares2L9Blueprint Medicines Corp$303.83Mreported value+2.71M sharesARGXArgenx SE$157.71Mreported value+536.3K sharesFOLDAmicus Therapeutics Inc$154.21Mreported value+6.68M sharesASNDAscendis Pharma A/s$149.19Mreported value+894.5K sharesFATEFate Therapeutics, Inc.$80.35Mreported value+883.7K sharesZYMEZymeworks Inc.$46.16Mreported value+976.7K sharesFMTXForma Therapeutics Holdings, Inc.$27.92Mreported value+800.0K sharesXPXp Inc.$3.20Mreported value+80.6K shares